Relay Therapeutics vs Vividion Therapeutics

Relay Therapeutics vs Vividion Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Relay Therapeutics is on 58/100 and Vividion Therapeutics on 22/100.

Relay Therapeutics logo
Relay TherapeuticsClinical-stage precision medicine company using protein motion insights for drug discovery.
Try Relay Therapeutics
Vividion Therapeutics logo
Vividion TherapeuticsBiopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
Try Vividion Therapeutics

Where each one leads

Relay Therapeutics

  • our overall score: 58/100 against 22/100
  • domain rating: 45/100 against 35/100
  • funding raised: $825M against $267M

Vividion Therapeutics

Leads on none of the measures we hold for both companies.

At a glance

MeasureRelay TherapeuticsVividion Therapeutics
What it isClinical-stage precision medicine company using protein motion insights for drug discovery.Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
CategoryBiotech, Drug Discovery, Precision Medicine, OncologyBiotech, Drug Discovery, Oncology, Therapeutics
Sells toBusiness modelB2BB2B
OfferingPlatformBiotech
Founded20152017
HeadquartersCambridge, United StatesSan Diego, United States
StatusActiveActive

Size, funding and growth

MeasureRelay TherapeuticsVividion Therapeutics
EmployeesNot published265
Total funding$825M$267M
Latest roundPublic OfferingSeries C
LinkedIn followersNot published18,737

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureRelay TherapeuticsVividion Therapeutics
StartupHub scoreOur 0-100 rating58/10022/100
Traction40/10040/100
Team70/10030/100
Community8/10015/100
Search visibility14/100Not published
Quality68/100Not published
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (42/100)
Domain ratingLink authority, 0-10045/10035/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureRelay TherapeuticsVividion Therapeutics
HostingNot detectedGoogle Cloud
CDNCloudflareNot detected
CMSWordPressWordPress
FrameworksJqueryJquery, Bootstrap
AnalyticsLinkedin InsightGoogle Analytics 4

Relay Therapeutics vs Vividion Therapeutics: common questions

Which is better, Relay Therapeutics or Vividion Therapeutics?

On our 0-100 score Relay Therapeutics rates higher (58/100 against 22/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do Relay Therapeutics and Vividion Therapeutics compare on the numbers?

Relay Therapeutics leads on our overall score (58/100 against 22/100), domain rating (45/100 against 35/100), funding raised ($825M against $267M).

Read the full Relay Therapeutics review and pricing or the Vividion Therapeutics review and pricing. You can also browse other Relay Therapeutics alternatives we track.